Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

Keyphrases

• Deregulation 100%
• Histone Methyltransferase 100%
• Enhancer of Zeste Homolog 2 (EZH2) 100%
• Lysine 100%
• Oncogenic Transformation 100%
• SUV39H1 100%
• Epigenetic Modification 50%
• Therapeutic Target 50%
• Small Interfering RNA (siRNA) 50%
• Oncogenesis 50%
• Telomerase 50%
• Tumor Progression 50%
• Tumorigenesis 50%
• Cell Proliferation 50%
• Gene Expression 50%
• G1 Arrest 50%
• Induced Apoptosis 50%
• Histone Methylation 50%
• Epigenetics 50%
• Protein Function 50%
• Colony Growth 50%
• Lysine Methylation 50%
• Transformed Cells 50%
• Gene Methylation 50%
• Soft Agar 50%
• SETDB1 50%
• Reduced Cell 50%
• Genetic mutation 50%
• Lung Cancer Model 50%
• Histone Tails 50%
• Immortalized Cell 50%
• Anchorage-independent 50%
• SV40 Large T Antigen 50%
• Immortal 50%
• Nucleosomal Histones 50%
• Histone Lysine Methylation 50%
• Aberrant DNA Methylation 50%
• Normal Human Bronchial Epithelial Cells 50%

Biochemistry, Genetics and Molecular Biology

• Carcinogenesis 100%
• Methyltransferase 100%
• Histone 100%
• Lysine 100%
• Methylation 33%
• EZH2 33%
• SUV39H1 33%
• Genetics 16%
• Transcription 16%
• Cell Proliferation 16%
• DNA Methylation 16%
• Epigenetic Modification 16%
• Tumor Progression 16%
• G1/S Transition 16%
• Epigenomics 16%
• Gene Mutation 16%
• Gene Expression 16%
• Epigenetics 16%
• Protein Function 16%
• Normal Human 16%
• Histone Methylation 16%
• Telomerase 16%
• Agar 16%
• SV40 Large T Antigen 16%
• SETDB1 16%
• Programmed Cell Death 16%
• Cancer Model 16%
• Small Interfering RNA 16%